Free. Unsubscribe any time.
ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 14 transactions and 937,410 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-07-06, came on the same day as the one before it (2026-07-06) and reports 5 transactions against 3 in the filing before it.
- The sales it reports total 159,478 shares, 28,268 more than the 131,210 in the filing before it.
- Its 10 filings on file run from 2026-01-21 to 2026-07-06, and state 5 plan adoption dates, from 2024-09-04 to 2026-03-13.
Trades in ImmunityBio, Inc. 14
- Selecky Christobel — 2026-01-16 · S · 50,000 shares
- Selecky Christobel — 2026-01-20 · S · 25,000 shares
- Simon Barry J. — 2026-01-20 · S · 76,967 shares
- Simon Barry J. — 2026-01-20 · S · 75,000 shares
- Simon Barry J. — 2026-02-20 · S · 10,000 shares
- Selecky Christobel — 2026-02-23 · S · 25,000 shares
- Simon Barry J. — 2026-02-23 · S · 165,000 shares
- Simon Barry J. — 2026-02-24 · S · 75,000 shares
- Simon Barry J. — 2026-06-04 · S · 23,033 shares
- Simon Barry J. — 2026-06-24 · S · 25,000 shares
- Selecky Christobel — 2026-06-29 · S · 95,722 shares
- Selecky Christobel — 2026-06-30 · S · 1,000 shares
Adoption dates in ImmunityBio, Inc. 5
- 2024-09-04 — stated in 3 filings
- 2025-06-12 — stated in 2 filings
- 2025-12-18 — stated in 2 filings
- 2026-02-27 — stated in 1 filing
- 2026-03-13 — stated in 2 filings
Results prints in ImmunityBio, Inc. 0
Trades before a print in ImmunityBio, Inc. 0
Interval to ImmunityBio, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 14no later print
Adoption dates ImmunityBio, Inc. states
- 2024-09-04 in 3 filings
- 2025-06-12 in 2 filings
- 2025-12-18 in 2 filings
- 2026-02-27 in 1 filing
- 2026-03-13 in 2 filings
Filing text: “10b5-1 trading plan entered into by the Reporting Person on February 27, 2026”
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
ImmunityBio, Inc.’s insider trading plan record — 10 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001326110.